Company registration number SC550705 (Scotland)
DURACARE LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
DURACARE LIMITED
COMPANY INFORMATION
Directors
Mr P Mann
Mr M Lindberg
Mr I Lindberg
Mr B M Lindberg
Mr A Lindberg
Company number
SC550705
Registered office
4 Symington Place
Riverside Business Park
Irvine
Ayrshire
United Kingdom
KA11 5DE
Auditor
Azets Audit Services
Titanium 1
Kings Inch Place
Renfrew
United Kingdom
PA4 8WF
DURACARE LIMITED
CONTENTS
Page
Strategic report
1
Directors' report
2
Directors' responsibilities statement
3
Independent auditor's report
4 - 7
Statement of comprehensive income
8
Balance sheet
9
Statement of changes in equity
10
Statement of cash flows
11
Notes to the financial statements
12 - 24
DURACARE LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 1 -

The directors present the strategic report for the year ended 31 December 2024.

Review of the business

The directors are satisfied with the performance throughout the year despite challenges in relation to import freight costs.

 

The results for the year show a profit of £2,703,161 before tax generated from turnover of £18,284,239. Net assets of the company amount to £3,635,571.

Principal risks and uncertainties

The directors recognise that the main risks are in relation to buying and shipping costs along with the sectors supply and demand fluctuations. The company continues to review its policies and procedures to mitigate the impact of these risks to the business.  

Key performance indicators

2024 2023

 

Turnover

£18,284,239 £16,942,839

 

Gross profit

40.85% 38.56%

 

Net Assets

£3,635,571 £4,588,188

 

 

The company considers gross profit margin to be the most important key performance indicator.

On behalf of the board

Mr B M Lindberg
Director
17 September 2025
DURACARE LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -

The directors present their annual report and financial statements for the year ended 31 December 2024.

Principal activities

The principal activity of the company continued to be the supply of consumables, medical equipment, furniture, and servicing solutions to Care Home Operators.

Results and dividends

The results for the year are set out on page 8.

Ordinary dividends were paid amounting to £969,040. The directors do not recommend payment of a further dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr P Mann
Mr M Lindberg
Mr I Lindberg
Mr D Lindberg
(Resigned 28 October 2024)
Mr B M Lindberg
Mr A Lindberg
Future developments

The company intends to continue to focus on its core activities and expand market share. Shareholders are pleased to report a satisfactory performance post year end.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

On behalf of the board
Mr B M Lindberg
Director
17 September 2025
DURACARE LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

DURACARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF DURACARE LIMITED
- 4 -
Opinion

We have audited the financial statements of Duracare Limited (the 'company') for the year ended 31 December 2024 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

DURACARE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF DURACARE LIMITED
- 5 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

DURACARE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF DURACARE LIMITED
- 6 -

Extent to which the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above and on the Financial Reporting Council’s website, to detect material misstatements in respect of irregularities, including fraud.

 

We obtain and update our understanding of the entity, its activities, its control environment, and likely future developments, including in relation to the legal and regulatory framework applicable and how the entity is complying with that framework.  Based on this understanding, we identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion.  This includes consideration of the risk of acts by the entity that were contrary to applicable laws and regulations, including fraud.

 

In response to the risk of irregularities and non-compliance with laws and regulations, including fraud, we designed procedures which included:

 

 

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation.  This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance.  The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

DURACARE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF DURACARE LIMITED
- 7 -

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

David MacCallum
Senior Statutory Auditor
For and on behalf of Azets Audit Services
25 September 2025
Chartered Accountants
Statutory Auditor
Titanium 1
Kings Inch Place
Renfrew
United Kingdom
PA4 8WF
DURACARE LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024
- 8 -
2024
2023
Notes
£
£
Turnover
3
18,284,239
16,942,839
Cost of sales
(10,814,324)
(10,409,132)
Gross profit
7,469,915
6,533,707
Distribution costs
(1,761,395)
(1,553,011)
Administrative expenses
(3,026,770)
(3,629,198)
Other operating income
34,702
-
0
Operating profit
4
2,716,452
1,351,498
Interest receivable and similar income
6
63,239
40,511
Interest payable and similar expenses
7
(76,530)
(65,478)
Profit before taxation
2,703,161
1,326,531
Tax on profit
8
(667,278)
(329,197)
Profit for the financial year
2,035,883
997,334

The profit and loss account has been prepared on the basis that all operations are continuing operations.

DURACARE LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 9 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
10
710,248
698,183
Current assets
Stocks
11
1,704,042
1,839,716
Debtors
12
3,097,964
3,275,372
Cash at bank and in hand
778,520
1,057,723
5,580,526
6,172,811
Creditors: amounts falling due within one year
13
(2,383,900)
(2,014,126)
Net current assets
3,196,626
4,158,685
Total assets less current liabilities
3,906,874
4,856,868
Creditors: amounts falling due after more than one year
14
(99,905)
(93,597)
Provisions for liabilities
Deferred tax liability
17
171,398
175,083
(171,398)
(175,083)
Net assets
3,635,571
4,588,188
Capital and reserves
Called up share capital
19
100
120
Capital redemption reserve
20
-
0
Profit and loss reserves
3,635,451
4,588,068
Total equity
3,635,571
4,588,188
The financial statements were approved by the board of directors and authorised for issue on 17 September 2025 and are signed on its behalf by:
Mr B M Lindberg
Director
Company Registration No. SC550705
DURACARE LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 10 -
Share capital
Capital redemption reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 January 2023
120
-
0
4,346,717
4,346,837
Year ended 31 December 2023:
Profit and total comprehensive income for the year
-
-
997,334
997,334
Dividends
9
-
-
(755,983)
(755,983)
Balance at 31 December 2023
120
-
0
4,588,068
4,588,188
Year ended 31 December 2024:
Profit and total comprehensive income for the year
-
-
2,035,883
2,035,883
Dividends
9
-
-
(969,040)
(969,040)
Redemption of shares
19
(20)
20
(2,019,460)
(2,019,460)
Balance at 31 December 2024
100
20
3,635,451
3,635,571
DURACARE LIMITED
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 11 -
2024
2023
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
22
3,560,375
1,925,936
Interest paid
(76,530)
(65,478)
Income taxes paid
(589,790)
(19,795)
Net cash inflow from operating activities
2,894,055
1,840,663
Investing activities
Purchase of tangible fixed assets
(300,902)
(376,272)
Proceeds from disposal of tangible fixed assets
77,346
39,825
Interest received
63,239
40,511
Net cash used in investing activities
(160,317)
(295,936)
Financing activities
Redemption of shares
(2,019,460)
-
0
Repayment of borrowings
(12,499)
92,702
Payment of finance leases obligations
(11,942)
9,997
Dividends paid
(969,040)
(755,983)
Net cash used in financing activities
(3,012,941)
(653,284)
Net (decrease)/increase in cash and cash equivalents
(279,203)
891,443
Cash and cash equivalents at beginning of year
1,057,723
166,280
Cash and cash equivalents at end of year
778,520
1,057,723
DURACARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 12 -
1
Accounting policies
Company information

Duracare Limited is a private company limited by shares incorporated in Scotland. The registered office is 4 Symington Place, Riverside Business Park, Irvine, Ayrshire, United Kingdom, KA11 5DE.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention.The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.4
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
20% reducing balance and 20% straight line
Motor vehicles
25% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

DURACARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 13 -
1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Financial instruments
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

DURACARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 14 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

DURACARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 15 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.14
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

DURACARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 16 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

 

The key sources of estimation that have been applied are detailed below:    

 

Valuation of shares repurchased

The the fair value of the shares repurchased during the year has been determined by reference to a multiple of EBITDA. This valuation method has been agreed between the shareholders.

3
Turnover

An analysis of the company's turnover is as follows:

2024
2023
£
£
Turnover analysed by class of business
Supply of consumables. medical equipment, furniture and servicing solutions
18,284,239
16,942,839
4
Operating profit
2024
2023
Operating profit for the year is stated after charging/(crediting):
£
£
Exchange (gains)/losses
-
0
126
Research and development costs
440
-
Fees payable to the company's auditor for the audit of the company's financial statements
23,100
22,000
Depreciation of owned tangible fixed assets
186,629
161,877
Depreciation of tangible fixed assets held under finance leases
12,562
5,695
Loss/(profit) on disposal of tangible fixed assets
4,172
(9,263)
Operating lease charges
52,965
43,530
5
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Staff
59
51
DURACARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
5
Employees
(Continued)
- 17 -

Their aggregate remuneration comprised:

2024
2023
£
£
Wages and salaries
2,380,761
2,062,922
Social security costs
233,068
192,132
Pension costs
48,007
40,734
2,661,836
2,295,788
6
Interest receivable and similar income
2024
2023
£
£
Interest income
Interest on bank deposits
63,208
40,511
Other interest income
31
-
0
Total income
63,239
40,511
2024
2023
Investment income includes the following:
£
£
Interest on financial assets not measured at fair value through profit or loss
63,208
40,511
7
Interest payable and similar expenses
2024
2023
£
£
Interest on financial liabilities measured at amortised cost:
Other interest on financial liabilities
65,267
64,829
Other finance costs:
Interest on finance leases and hire purchase contracts
-
649
Other interest
11,263
-
0
76,530
65,478
8
Taxation
2024
2023
£
£
Current tax
UK corporation tax on profits for the current period
670,963
275,774
DURACARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
8
Taxation
2024
2023
£
£
(Continued)
- 18 -
Deferred tax
Origination and reversal of timing differences
(3,685)
53,423
Total tax charge
667,278
329,197

The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

2024
2023
£
£
Profit before taxation
2,703,161
1,326,531
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2023: 23.52%)
675,790
312,000
Tax effect of expenses that are not deductible in determining taxable profit
5,931
32,778
Gains not taxable
1,043
(2,179)
Deferred tax
(3,685)
53,423
Fixed asset differences
(9,909)
(35,145)
Other adjustments
(1,892)
(31,680)
Taxation charge for the year
667,278
329,197
9
Dividends
2024
2023
£
£
Final paid
80,000
-
Interim paid
889,040
755,983
969,040
755,983
DURACARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 19 -
10
Tangible fixed assets
Fixtures and fittings
Motor vehicles
Total
£
£
£
Cost
At 1 January 2024
589,173
545,971
1,135,144
Additions
134,515
207,387
341,902
Disposals
(33,310)
(126,096)
(159,406)
At 31 December 2024
690,378
627,262
1,317,640
Depreciation and impairment
At 1 January 2024
242,643
194,318
436,961
Depreciation charged in the year
92,844
106,347
199,191
Eliminated in respect of disposals
(33,310)
(44,578)
(77,888)
Other movements
73,257
(24,129)
49,128
At 31 December 2024
375,434
231,958
607,392
Carrying amount
At 31 December 2024
314,944
395,304
710,248
At 31 December 2023
346,530
351,653
698,183

The net carrying value of tangible fixed assets includes the following in respect of assets held under finance leases or hire purchase contracts.

2024
2023
£
£
Motor vehicles
70,749
31,151

 

11
Stocks
2024
2023
£
£
Work in progress
25,407
37,474
Finished goods and goods for resale
1,678,635
1,802,242
1,704,042
1,839,716
DURACARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 20 -
12
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
2,633,019
2,715,165
Other debtors
380,142
423,683
Prepayments and accrued income
84,803
136,524
3,097,964
3,275,372
13
Creditors: amounts falling due within one year
2024
2023
Notes
£
£
Obligations under finance leases
16
19,535
9,284
Other borrowings
15
12,499
12,499
Trade creditors
651,499
821,958
Corporation tax
354,603
273,430
Other taxation and social security
334,262
112,096
Other creditors
950,189
738,628
Accruals and deferred income
61,313
46,231
2,383,900
2,014,126

Obligations under finance leases are secured over the assets to which they relate.

14
Creditors: amounts falling due after more than one year
2024
2023
Notes
£
£
Obligations under finance leases
16
32,201
13,394
Other borrowings
15
67,704
80,203
99,905
93,597

Obligations under finance leases are secured over the assets to which they relate.

15
Loans and overdrafts
2024
2023
£
£
Other loans
80,203
92,702
Payable within one year
12,499
12,499
Payable after one year
67,704
80,203

 

DURACARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 21 -
16
Finance lease obligations
2024
2023
Future minimum lease payments due under finance leases:
£
£
Within one year
19,535
9,284
In two to five years
32,201
13,394
51,736
22,678

Finance lease payments represent rentals payable by the company for certain items of plant and machinery. Leases include purchase options at the end of the lease period, and no restrictions are placed on the use of the assets. All leases are on a fixed repayment basis and no arrangements have been entered into for contingent rental payments.

17
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

Liabilities
Liabilities
2024
2023
Balances:
£
£
Accelerated capital allowances
171,398
175,083
2024
Movements in the year:
£
Liability at 1 January 2024
175,083
Credit to profit or loss
(3,685)
Liability at 31 December 2024
171,398

The deferred tax liability set out above is expected to reverse within 12 months and relates to accelerated capital allowances that are expected to mature within the same period.

18
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
48,007
40,734

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

DURACARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 22 -
19
Share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A of £1 each
20
20
20
20
Ordinary B of £1 each
20
20
20
20
Ordinary C of £1 each
0
20
-
0
20
Ordinary D of £1 each
20
20
20
20
Ordinary E of £1 each
20
20
20
20
Ordinary F of £1 each
20
20
20
20
100
120
100
120

Each share has full rights in the company with respect to voting dividends and distributions.

On 15 October 2024, 20 ordinary C shares of £1 were repurchased, and subsequently cancelled, at a price of £100,973 per share.

20
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

2024
2023
£
£
Within one year
105,000
105,000
Between two and five years
420,000
420,000
In over five years
525,000
630,000
1,050,000
1,155,000
21
Related party transactions
Transactions with related parties

During the year the company entered into the following transactions with related parties:

Sales
Sales
Purchases
Purchases
2024
2023
2024
2023
£
£
£
£
Other related parties
108,689
203,672
2,159,968
2,227,296
Management charge
2024
2023
£
£
Other related parties
-
1,042,433
DURACARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
21
Related party transactions
(Continued)
- 23 -
2024
2023
Amounts due to related parties
£
£
Directors' loan accounts
495,314
549,175
Other related parties
292,845
48,802

The amounts are unsecured and have no fixed terms of repayment. Interest is charged at base rate plus 6.5% per annum (2023: base rate plus 6.5%).

The following amounts were outstanding at the reporting end date:

2024
2023
Amounts due from related parties
£
£
Other related parties
732
168,350

The balance has no fixed repayment terms, interest is not charged on the oustanding balance and is unsecured.

22
Cash generated from operations
2024
2023
£
£
Profit for the year after tax
2,035,883
997,334
Adjustments for:
Taxation charged
667,278
329,197
Finance costs
76,530
65,478
Investment income
(63,239)
(40,511)
Loss/(gain) on disposal of tangible fixed assets
4,172
(9,263)
Depreciation and impairment of tangible fixed assets
199,191
167,572
Other fixed asset movements
49,128
-
Movements in working capital:
Decrease/(increase) in stocks
135,674
(46,582)
Decrease/(increase) in debtors
177,408
(603,084)
Increase in creditors
278,350
1,065,795
Cash generated from operations
3,560,375
1,925,936
DURACARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 24 -
23
Analysis of changes in net funds
1 January 2024
Cash flows
New finance leases
31 December 2024
£
£
£
£
Cash at bank and in hand
1,057,723
(279,203)
-
778,520
Borrowings excluding overdrafts
(92,702)
12,499
-
(80,203)
Obligations under finance leases
(22,678)
11,942
(41,000)
(51,736)
942,343
(254,762)
(41,000)
646,581
2024-12-312024-01-01falsefalsefalseCCH SoftwareCCH Accounts Production 2025.100Mr P MannMr M LindbergMr I LindbergMr D LindbergMr B M LindbergMr A LindbergSC5507052024-01-012024-12-31SC550705bus:Director12024-01-012024-12-31SC550705bus:Director22024-01-012024-12-31SC550705bus:Director32024-01-012024-12-31SC550705bus:Director52024-01-012024-12-31SC550705bus:Director62024-01-012024-12-31SC550705bus:Director42024-01-012024-12-31SC550705bus:RegisteredOffice2024-01-012024-12-31SC5507052024-12-31SC5507052023-01-012023-12-31SC550705core:RetainedEarningsAccumulatedLosses2023-01-012023-12-31SC550705core:RetainedEarningsAccumulatedLosses2024-01-012024-12-31SC5507052023-12-31SC550705core:FurnitureFittings2024-12-31SC550705core:MotorVehicles2024-12-31SC550705core:FurnitureFittings2023-12-31SC550705core:MotorVehicles2023-12-31SC550705core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-31SC550705core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-31SC550705core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-31SC550705core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-31SC550705core:CurrentFinancialInstruments2024-12-31SC550705core:CurrentFinancialInstruments2023-12-31SC550705core:Non-currentFinancialInstruments2024-12-31SC550705core:Non-currentFinancialInstruments2023-12-31SC550705core:ShareCapital2024-12-31SC550705core:ShareCapital2023-12-31SC550705core:CapitalRedemptionReserve2024-12-31SC550705core:CapitalRedemptionReserve2023-12-31SC550705core:RetainedEarningsAccumulatedLosses2024-12-31SC550705core:RetainedEarningsAccumulatedLosses2023-12-31SC550705core:ShareCapital2022-12-31SC550705core:CapitalRedemptionReserve2022-12-31SC550705core:RetainedEarningsAccumulatedLosses2022-12-31SC550705core:ShareCapitalOrdinaryShareClass12024-12-31SC550705core:ShareCapitalOrdinaryShareClass12023-12-31SC550705core:ShareCapitalOrdinaryShareClass22024-12-31SC550705core:ShareCapitalOrdinaryShareClass22023-12-31SC550705core:ShareCapitalOrdinaryShareClass32024-12-31SC550705core:ShareCapitalOrdinaryShareClass32023-12-31SC550705core:ShareCapitalOrdinaryShareClass42024-12-31SC550705core:ShareCapitalOrdinaryShareClass42023-12-31SC550705core:ShareCapitalOrdinaryShareClass52024-12-31SC550705core:ShareCapitalOrdinaryShareClass52023-12-31SC550705core:ShareCapitalOrdinaryShares2024-12-31SC550705core:ShareCapitalOrdinaryShares2023-12-31SC550705core:ShareCapital2024-01-012024-12-31SC5507052023-12-31SC5507052022-12-31SC550705core:FurnitureFittings2024-01-012024-12-31SC550705core:MotorVehicles2024-01-012024-12-31SC55070512024-01-012024-12-31SC55070512023-01-012023-12-31SC550705core:UKTax2024-01-012024-12-31SC550705core:UKTax2023-01-012023-12-31SC55070522024-01-012024-12-31SC55070522023-01-012023-12-31SC55070532024-01-012024-12-31SC55070532023-01-012023-12-31SC55070542024-01-012024-12-31SC55070542023-01-012023-12-31SC550705core:FurnitureFittings2023-12-31SC550705core:MotorVehicles2023-12-31SC550705core:WithinOneYear2024-12-31SC550705core:WithinOneYear2023-12-31SC550705core:BetweenTwoFiveYears2024-12-31SC550705core:BetweenTwoFiveYears2023-12-31SC550705bus:OrdinaryShareClass12024-01-012024-12-31SC550705bus:OrdinaryShareClass22024-01-012024-12-31SC550705bus:OrdinaryShareClass32024-01-012024-12-31SC550705bus:OrdinaryShareClass52024-01-012024-12-31SC550705bus:OrdinaryShareClass42024-01-012024-12-31SC550705bus:OrdinaryShareClass12024-12-31SC550705bus:OrdinaryShareClass12023-12-31SC550705bus:OrdinaryShareClass22024-12-31SC550705bus:OrdinaryShareClass22023-12-31SC550705bus:OrdinaryShareClass32024-12-31SC550705bus:OrdinaryShareClass32023-12-31SC550705bus:OrdinaryShareClass42024-12-31SC550705bus:OrdinaryShareClass42023-12-31SC550705bus:OrdinaryShareClass52024-12-31SC550705bus:OrdinaryShareClass52023-12-31SC550705bus:AllOrdinaryShares2024-12-31SC550705bus:AllOrdinaryShares2023-12-31SC550705core:MoreThanFiveYears2024-12-31SC550705core:MoreThanFiveYears2023-12-31SC550705core:OtherRelatedPartiescore:SaleOrPurchaseGoods2024-01-012024-12-31SC550705bus:PrivateLimitedCompanyLtd2024-01-012024-12-31SC550705bus:FRS1022024-01-012024-12-31SC550705bus:Audited2024-01-012024-12-31SC550705bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP